After purchasing more shares of this biotech stock this week I am now in a position to share with the message board this stock that I like so much. I came across this company several months ago by happen chance, and thus far it has been a real winner with lots of room to run.
One reason I like this stock includes the deep pipeline of drugs that appear to have a bright future. Take a look at some recent SEC filings and you will find that they have 5 or 6 products that appear posed to be real winners. They also recently signed a licenses marketing agreement on just one of their promising drugs (CCX168). The monetary compensation of this deal is $85MM upfront with total potential compensation up to $600MM. Up until this agreement was signed the market cap was just above $100MM, and had decreased significantly over the last year or two. Since this agreement occurred the stock has more than doubled.
I first bought this this stock back in early April, and have purchased it several times since then. To conclude I like the biotech industry because of the large amount of cash companies have on hand, and the potential to earn an outstanding return on my money. With research of the SEC filings I feel like you can sift through the winners and losers, but it does take time and lots of research.
http://finance.yahoo.com/q?s=CCXI
http://www.streetinsider.com/Corporate+News/Vifor+Pharma+Licenses+Marketing+Rights+to+ChemoCentryxs+(CCXI)+CCX168/11608024.html
Mark P.
One reason I like this stock includes the deep pipeline of drugs that appear to have a bright future. Take a look at some recent SEC filings and you will find that they have 5 or 6 products that appear posed to be real winners. They also recently signed a licenses marketing agreement on just one of their promising drugs (CCX168). The monetary compensation of this deal is $85MM upfront with total potential compensation up to $600MM. Up until this agreement was signed the market cap was just above $100MM, and had decreased significantly over the last year or two. Since this agreement occurred the stock has more than doubled.
I first bought this this stock back in early April, and have purchased it several times since then. To conclude I like the biotech industry because of the large amount of cash companies have on hand, and the potential to earn an outstanding return on my money. With research of the SEC filings I feel like you can sift through the winners and losers, but it does take time and lots of research.
http://finance.yahoo.com/q?s=CCXI
http://www.streetinsider.com/Corporate+News/Vifor+Pharma+Licenses+Marketing+Rights+to+ChemoCentryxs+(CCXI)+CCX168/11608024.html
Mark P.